Not logged inMaintenance capecitabine plus ramucirumab after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma (OGA): Final analysis from the PLATFORM trial
Gordon, A.; Rajan, Z.; Fong, C. Y. K.; Peckitt, C.; Satchwell, L.; Cromarty, S.; Kidd, S.; Piadel, K.; Leamon, B.; Zhitkov, O.; Davidson, M.; Thompson, J.; Maisey, N. R.; Darby, S.; Waddell, T. S.; Morgan, C.; Bradshaw, A.; Starling, N.; Chau, I.; Cunningham, D. .png)
Share.png)
SaveMaintenance durvalumab after fi rst-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM studyFong, C.; Patel, B.; Peckitt, C.; Bourmpaki, E.; Satchwell, L.; Cromarty, S.; Kidd, S.; von Loga, K.; Uhlik, M.; Begum, R.; Rana, T.; Waddell, T.; Darby, S.; Bradshaw, A.; Roques, T.; Morgan, C.; Rees, C.; Herbertson, R.; Das, P.; Thompson, C.; Hewish, M.; Petty, R.; Thistlethwaite, F.; Rao, S.; Starling, N.; Chau, I.; Cunningham, D. Share Save MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patientsLote, Hazel; Mousoullou, Florentia; Vlachogiannis, George; Lampis, Andrea; Satchwell, Laura; Peckitt, Clare; Fong, Caroline; Begum, Ruwaida; Kidd, Shannon; Cromarty, Susan; Gordon, Anderley; Fribbens, Charlotte; Rao, Sheela; Starling, Naureen; Chau, Ian; Cunningham, David; Valeri, Nicola Share Save Genetic and immune landscape evolution in MMR-deficient colorectal cancerChalloner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Fong, Caroline; Barber, Louise J.; Anandappa, Gayathri; Crux, Richard; Assiotis, Ioannis; Fenwick, Kerry; Begum, Ruwaida; Begum, Dipa; Lund, Tom; Sivamanoharan, Nanna; Sansano, Harold B.; Domingo-Arada, Melissa; Tran, Amina; Pandha, Hardev; Church, David; Eccles, Bryony; Ellis, Richard; Falk, Stephen; Hill, Mark; Krell, Daniel; Murugaesu, Nirupa; Nolan, Luke; Potter, Vanessa; Saunders, Mark; Shiu, Kai-Keen; Guettler, Sebastian; Alexander, James L.; Lazare-Iglesias, Hector; Kinross, James; Murphy, Jamie; von Loga, Katharina; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save Maintenance rucaparib after first-line platinum-based chemotherapy in advanced esophagogastric (OG) adenocarcinoma: Interim results from the PLATFORM trialGordon, A.; Fong, C. Y. K.; Davidson, M.; Cromarty, S.; Kidd, S.; Piadel, K.; Peckitt, C.; Satchwell, L.; Rajan, Z.; Begum, R.; Zhitkov, O.; Das, P.; Sothi, S.; Herbertson, R. A.; Darby, S.; Waddell, T. S.; Bradshaw, A.; Starling, N.; Chau, I.; Cunningham, D. Share Save Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centreLau, David K.; Fong, Caroline; Arouri, Faten; Cortez, Lillian; Katifi, Hannah; Gonzalez-Exposito, Reyes; Razzaq, Muhammad Bilal; Li, Su; Macklin-Doherty, Aislinn; Hernandez, Monica Arenas; Hubank, Michael; Fribbens, Charlotte; Watkins, David; Rao, Sheela; Chau, Ian; Cunningham, David; Starling, Naureen Share Save Share Save Clonal mutation burden and evolutionary dynamics analysis in metastatic gastro-esophageal adenocarcinoma (GEA) by error corrected whole-exome circulating tumor DNA sequencingMcCafferty, Neil; Fong, Caroline; Barber, Louise J.; Woolston, Andrew; Kleftogiannis, Dimitrios; Rana, Taqia; Cromarty, Susan; Kidd, Shannon; Begum, Ruwaida; Chau, Ian; Starling, Naureen; Cunningham, David; Gerlinger, Marco Share Save Share Save Routine DPYD mutation testing for patients receiving fluoropyrimidines for gastrointestinal (GI) cancers: Real world experience in a tertiary UK oncology centreLau, D. K. W.; Fong, C.; Arouri, F.; Cortez, L.; Katifi, H.; Gonzalez-Exposito, R.; Razzaq, M. B.; Li, S.; Macklin-Doherty, A.; Fribbens, C.; Watkins, D.; Rao, S.; Chau, I.; Cunningham, D.; Starling, N. Share Save Share Save Share Save The optimal use of PEG-Asparaginase in relapsed ALL-lessons from the ALLR3 Clinical TrialMasurekar, A.; Fong, C.; Hussein, A.; Revesz, T.; Hoogerbrugge, P. M.; Love, S.; Ciria, C.; Parker, C.; Krishnan, S.; Saha, V. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}